Thank you for subscribing!
Next Investors Mar 08, 2024
Yesterday, our biotech investment Emyria (ASX:EMD) was up 37% on no news.
Next Investors Sep 05, 2023
In today's note we deep dive into the 8 reasons we Invested in Emyria (ASX:EMD). EMD is an integrated clinical drug development and care delivery company whose primary area of focus is on psychedelics such MDMA, psilocybin and more recently, ketamine for treatment of mental health disorders
Finfeed Archived Jun 15, 2020
eSense-Lab Limited (ASX: ESE) has entered a JV with ANC Enterprises to provide specific terpenes uniquely developed for a range of skin care, hair care and hand sanitiser products. ANC will formulate and manufacture the resulting products containing ESE’s proprietary terpene mixes.
Finfeed Archived Jun 04, 2020
PharmAust's (ASX:PAA) demonstrates both infectivity and replication of SARS-CoV-2 virus particles can be suppressed in cell cultures.
Get expert stock analysis direct in your inbox
Finfeed Archived May 22, 2020
Genetic Technologies (ASX: GTG | NASDAQ: GENE) is fast-tracking development of a genetic test that will determine if people are at a high risk of contracting COVID-19.
Join Our Mailing List
